AMAG Pharmaceuticals, Inc. (AMAG) Financial Statements (2024 and earlier)

Company Profile

Business Address 1100 WINTER STREET
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2020
MRQ
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 171,751394,171328,707579,086466,331144,186
Cash and cash equivalents 113,009253,256192,114274,305228,705119,296
Short-term investments 58,742140,915136,593304,781237,62624,890
Receivables 94,16385,347103,50192,37585,67838,172
Inventory, net of allowances, customer advances and progress billings 31,55326,69137,35637,25840,64540,610
Inventory 31,55326,69137,35637,25840,64540,610
Other undisclosed current assets 19,10018,96112,3049,83914,02051,068
Total current assets: 316,567525,170481,868718,558606,674274,036
Noncurrent Assets
Inventory, Noncurrent      7,798
Operating lease, right-of-use asset 23,286
Property, plant and equipment 4,1167,52125,99624,46028,7251,519
Intangible assets, net (including goodwill) 446,133639,5461,343,9541,731,6621,835,959539,471
Goodwill 422,513422,513639,484639,484639,188205,824
Intangible assets, net (excluding goodwill) 23,620217,033704,4701,092,1781,196,771333,647
Restricted cash and investments 4954956562,5932,5932,397
Deferred income tax assets 630
Other noncurrent assets  1,4677621,15313,48117,249
Other undisclosed noncurrent assets  1,260   546,463
Total noncurrent assets: 474,660650,2891,371,3681,759,8681,880,7581,114,897
TOTAL ASSETS: 791,2271,175,4591,853,2362,478,4262,487,4321,388,933
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 204,100144,024185,825159,692111,26998,288
Employee-related liabilities      10,176
Accounts payable 27,02114,48710,3353,6844,9067,301
Accrued liabilities 177,079129,537175,490156,008106,36380,811
Debt 4,07721,276 21,16617,50034,000
Restructuring reserve      1,952
Business combination, contingent consideration, liability 1714449,399  718
Deferred revenue and credits42,49434,95120,18544,376
Other undisclosed current liabilities    97,06896,967(12,846)
Total current liabilities: 208,194165,444277,718312,877245,921166,488
Noncurrent Liabilities
Long-term debt and lease obligation 296,825261,933734,683965,355985,640167,441
Long-term debt, excluding current maturities 277,034261,933734,683965,355985,640167,441
Liabilities, other than long-term debt 891,42750,591214,878198,015301,146
Deferred revenue and credits24,38714,8505,0935,543
Deferred tax liabilities, net 23,927197,066189,14577,619
Other liabilities 891,2121,5912,9623,777 
Operating lease, liability 19,791
Business combination, contingent consideration, liability  215686  217,984
Other undisclosed noncurrent liabilities    50,927125,592293,905
Total noncurrent liabilities: 296,914263,360785,2741,231,1601,309,247762,492
Total liabilities: 505,108428,8041,062,9921,544,0371,555,168928,980
Equity
Equity, attributable to parent 286,119746,655790,244934,389932,264459,953
Common stock 339346341343347256
Additional paid in capital 1,297,9171,292,7361,271,6281,238,0311,233,786793,757
Accumulated other comprehensive loss (3,239)(3,985)(3,908)(3,838)(4,205)(3,617)
Accumulated deficit (1,008,898)(542,442)(477,817)(300,147)(297,664)(330,443)
Total equity: 286,119746,655790,244934,389932,264459,953
TOTAL LIABILITIES AND EQUITY: 791,2271,175,4591,853,2362,478,4262,487,4321,388,933

Income Statement (P&L) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 327,751474,002609,946532,091418,276124,384
Revenue, net609,946532,091418,276124,384
Cost of revenue
(Cost of Goods and Services Sold)
 (107,193)(215,892)(183,166)(116,889)(88,501)(21,915)
Gross profit: 220,558258,110426,780415,202329,775102,469
Operating expenses (666,065)(305,156)(720,041)(336,332)(218,555)(112,912)
Other undisclosed operating income      6,606
Operating income (loss): (445,507)(47,046)(293,261)78,870111,220(3,837)
Nonoperating income (expense) (20,996)(82,639)(76,833)3,338(7,676)(13,505)
Investment income, nonoperating 4,2855,3282,8103,1491,5121,089
Other nonoperating income (expense) 428(74)(335)189(9,188) 
Interest and debt expense (25,709)(35,922)(10,926)(73,153)(63,700)(14,697)
Other undisclosed income from continuing operations before equity method investments, income taxes      14,697
Income (loss) from continuing operations before equity method investments, income taxes: (492,212)(165,607)(381,020)9,05539,844(17,342)
Other undisclosed income from continuing operations before income taxes 25,70935,92210,926   
Income (loss) from continuing operations before income taxes: (466,503)(129,685)(370,094)9,05539,844(17,342)
Income tax expense (benefit) 47(39,654)170,866(11,538)(7,065)153,159
Income (loss) from continuing operations: (466,456)(169,339)(199,228)(2,483)32,779135,817
Income (loss) before gain (loss) on sale of properties:(466,456)(152,837)(199,228)(2,483)32,779135,817
Income from discontinued operations  16,502    
Net income (loss): (466,456)(152,837)(199,228)(2,483)32,779135,817
Other undisclosed net income attributable to parent  87,076    
Net income (loss) available to common stockholders, diluted: (466,456)(65,761)(199,228)(2,483)32,779135,817

Comprehensive Income ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss): (466,456)(152,837)(199,228)(2,483)32,779135,817
Comprehensive income (loss): (466,456)(152,837)(199,228)(2,483)32,779135,817
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 74686,999(70)367(588)(126)
Comprehensive income (loss), net of tax, attributable to parent: (465,710)(65,838)(199,298)(2,116)32,191135,691

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: